The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

Table 3 Effects of turmeric on serum levels of lipid profile and malondialdehyde in patients with NAFLD

Variables	Placebo, n = 32	Turmeric, n = 32	P1
Triglycerides (mg/dL)
Before	176.44 ± 91.96	164.34 ± 80.12	0.577
After	155.62 ± 85.35	141.78 ± 65.57	0.470
P2	0.188	0.043
Total Cholesterol (mg/dL)
Before	194.50 ± 34.29	195.88 ± 35.38	0.875
After	182.62 ± 29.36	186.50 ± 36.49	0.641
P2	0.143	0.196
LDL (mg/dL)
Before	116.52 ± 27.11	121.93 ± 28.77	0.442
After	104.60 ± 22.99	108.40 ± 26.83	0.545
P2	0.052	0.035
HDL (mg/dL)
Before	42.45 ± 10.17	40.28 ± 6.66	0.316
After	44.59 ± 7.17	42.34 ± 4.13	0.129
P2	0.247	0.049
VLDL(mg/dL)
Before	36.17 ± 14.82	30.88 ± 15.02	0.161
After	33.63 ± 16.55	32.53 ± 16.52	0.791
P3	0.394	0.417
Cholesterol/HDL ratio
Before	4.71 ± .0.97	5.03 ± 1.37	0.294
After	4.16 ± 0.80	4.45 ± 1.00	0.211
P2	0.012	0.021
LDL/HDL ratio
Before	2.81 ± 0.72	3.12 ± 0.94	0.155
After	2.38 ± 0.59	2.57 ± 0.66	0.235
P2	0.005	0.003
MDA(mmol/L)
Before	0.278 ± 0.14	0.237 ± 0.13	0.241
After	0.189 ± 0.13	0.167 ± 0.10	0.487
P2	0.191	0.000

Values presented as mean ± SD
NAFLD nonalcoholic fatty liver disease, LDL low-density lipoprotein, HDL high-density lipoprotein, VLDL very low-density lipoprotein, Unit µM/L
^a,bP values indicate differences between the intervention and placebo groups at before and after intervention (Paired T Test)

ISSN: 1758-5996